Cite
APA Citation
Werth, B., Jain, R., Hahn, A., Cummings, L., Weaver, T., Waalkes, A., Sengupta, D., Salipante, S., Rakita, R., & Butler-Wu, S. (2018). emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen. Clinical microbiology and infection, 24, 429.e1–429.e5. http://access.bl.uk/ark:/81055/vdc_100058288281.0x000024